Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$2.34 - $4.43 $705,970 - $1.34 Million
301,697 New
301,697 $959,000
Q3 2021

Nov 15, 2021

SELL
$13.71 - $17.18 $17.6 Million - $22 Million
-1,281,600 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$14.92 - $23.23 $3.37 Million - $5.25 Million
-225,952 Reduced 14.99%
1,281,600 $21.3 Million
Q1 2021

May 12, 2021

SELL
$7.33 - $21.06 $2.2 Million - $6.32 Million
-300,002 Reduced 16.6%
1,507,552 $27.5 Million
Q4 2020

Feb 16, 2021

BUY
$3.63 - $7.53 $6.56 Million - $13.6 Million
1,807,554 New
1,807,554 $13.6 Million

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $505M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.